SF-36 PROSTALAC in situ compared with pre- and post-THR
| SF-36 domains | PROSTALAC cohort (n = 23), mean (SD) | Pre-THR population (n = 228), mean (SD)9 | p value* | 6-mo post-THR population (n = 228), mean (SD)9 | p value* |
|---|---|---|---|---|---|
| Physical functioning | 25.00 (22.4) | 20.8 (17.4) | 0.28 | 50.4 (26.9) | < 0.001 |
| Role physical | 20.65 (36.7) | 9.3 (22.0) | 0.03 | 47.4 (40.8) | 0.003 |
| Bodily pain | 45.39 (23.4) | 27.2 (14.3) | < 0.0001 | 63.2 (25.2) | 0.0013 |
| General health | 57.00 (22.3) | 62.6 (21.4) | 0.23 | 69.3 (23.5) | 0.017 |
| Vitality | 38.26 (21.6) | 41.3 (18.2) | 0.45 | 58.7 (21.8) | < 0.001 |
| Social function | 57.07 (34.5) | 52.1 (28.3) | 0.43 | 79.4 (25.2) | 0.0001 |
| Role emotional | 54.55 (48.8) | 44.8 (44.8) | 0.32 | 72.0 (39.6) | 0.05 |
| Mental health | 66.13 (27.2) | 67.4 (21.1) | 0.79 | 76.1 (20.3) | 0.03 |
SD = standard deviation
↵* Two-tailed Independent t test comparing our sample with the reference population at the indicated time interval.
PROSTALAC = Prosthesis with Antibiotic-Loaded Acrylic Cement, SD = standard deviation; THR = total hip replacement